Layer3.news

AI by layer3.news

Filtering by: Roger Song · clear filter

JEFFERIES MAINTAINS “BUY” RATING ON WAVE LIFE SCIENCES (WVE) AMID ITS IMPROVING COMPETITIVE POSITIONING

https://s.yimg.com/ny/api/res/1.2/35ywCKBuX8lI0hLXuNzrkA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/85d78460c549fa505d1be06247c106b6

✍️ Wave Life Sciences Ltd. (NASDAQ:WVE) is a clinical-stage biotech company with significant upside potential, according to analysts, and has secured a spot on the list of best small-cap biotech stocks to buy.

👉 Wave Life Sciences Ltd. (NASDAQ:WVE) has improved its competitive positioning 👉 The company reported its Q3 results, missing analyst forecasts of $12.89 million revenue 👉 Wave Life Sciences Ltd. (NASDAQ:WVE) reduced its net loss from $61.8 million in Q3 2024 to $53.9 million 👉 The company has extended its cash runway through Q2 2027

-- #RogerSong #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq20hlr5xp6nns6dmfccvccc9x2l3mxrdufkh4pg53wecv6kn09u0suk2lys

Roger Song business mainstream:perspective

11/17/2025

npub1vap2usg…grwc3n

JUST THE TONIC: THIS MEDICAL STOCK, A MUTUAL FUND DARLING, TESTS ENTRY AMID 58% RUN

https://www.investors.com/wp-content/uploads/2025/07/Stock-Money-pointGlasses-shut.jpg

✍️ Kiniksa Pharmaceuticals International (KNSA) is experiencing a powerful run, with institutional investors loading up on the stock, driven by its flagship drug Arcalyst and expected rebound to profitability.

👉 Kiniksa Pharmaceuticals is a formidable all-around performer with a 96 out of 99 IBD Composite Rating 👉 The company is expected to rebound to profitability this year with earnings of $1.05 per share 👉 Analysts rate the stock as a strong buy with a consensus rating of 42.60 and a 12-month price target of 54 👉 Institutional ownership is high, with 74% of shares currently being held by funds 👉 The company's flagship drug, Arcalyst, treats several inflammatory disorders

-- #WilliamJ.O'Neil #RogerSong #GeoffMeacham #MichaelLarkin #Bermuda #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqc0nka9ca87yztkw7z2z8p9c2ng7w5xc6f303lvthhj396ezt7lqqg5cjea

William J. O'Neil Roger Song Geoff Meacham Michael Larkin Bermuda health mainstream:perspective

8/1/2025

npub1n5e52z2…j27swa

FDA’S TOP VACCINE OFFICIAL LEAVES POST AFTER LESS THAN FOUR MONTHS

https://i.guim.co.uk/img/media/be7750f0b599996aa2bf6d4a7688b18d98929079/465_0_4652_3725/master/4652.jpg?width=140&quality=85&auto=format&fit=max&s=dce915b4d60bb06ffeb2c6bd61f50880

✍️ Vinay Prasad, the top vaccine official at the US FDA, has left the agency less than four months after being appointed, citing a desire to spend more time with his family.

👉 Vinay Prasad left the FDA after less than four months as the head of the division overseeing biological products 👉 He was a fierce critic of US Covid-19 vaccine and mask mandates 👉 He was appointed as the director of the FDA's center for biologics evaluation and research in May 👉 The FDA has taken unusual regulatory actions during his tenure, including limiting the use of Covid-19 vaccines and declining to approve certain treatments 👉 His departure has been met with a mixed reaction, with some analysts seeing it as a positive for gene therapy and vaccine makers

-- #VinayPrasad #KostasBilouris #RogerSong #UnitedStates #California #Washington #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq98hv9eu4jzke3y9snxq5z7uxlupq4keflc7ypvsnchxsna7q6cfq7hclsu

Vinay Prasad Kostas Bilouris Roger Song United States California Washington health liberal:perspective

7/30/2025

npub1vap2usg…grwc3n

JEFFERIES PREDICTS UP TO ~1000% SURGE FOR THESE 2 ‘STRONG BUY’ STOCKS

https://media.zenfs.com/en/tipranks_452/fb203f95ffee9f374f54e6aa062b8ef8

✍️ The article discusses the potential impact of a second Trump administration on the biotech sector, with Jefferies analysts predicting a growth-friendly environment and identifying two small biotech stocks with strong upside.

👉 Jefferies analysts predict a growth-friendly environment for the biotech sector under a second Trump administration 👉 Reduced regulation and lower corporate tax rates could boost the biotech sector 👉 Metagenomi is a biotech innovator unlocking the potential of gene editing through metagenomics 👉 Structure Therapeutics is a clinical-stage biopharmaceutical company developing new treatments for chronic conditions 👉 Jefferies analysts predict significant gains for Metagenomi and Structure Therapeutics, with Metagenomi potentially reaching $21 and Structure Therapeutics potentially reaching $79

-- #DeshPeramunetilleke #MauryRaycroft #RogerSong #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqx65jkkx0e47xtdke9tvyqyaqg74436faw28rw764l64pm602wcwqwcn280

Desh Peramunetilleke Maury Raycroft Roger Song health mainstream:perspective

12/8/2024

Layer3.news

AI by layer3.news

Filtering by: Roger Song · clear filter

npub1vap2usg…grwc3n

JEFFERIES MAINTAINS “BUY” RATING ON WAVE LIFE SCIENCES (WVE) AMID ITS IMPROVING COMPETITIVE POSITIONING

https://s.yimg.com/ny/api/res/1.2/35ywCKBuX8lI0hLXuNzrkA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/85d78460c549fa505d1be06247c106b6

✍️ Wave Life Sciences Ltd. (NASDAQ:WVE) is a clinical-stage biotech company with significant upside potential, according to analysts, and has secured a spot on the list of best small-cap biotech stocks to buy.

-- #RogerSong #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq20hlr5xp6nns6dmfccvccc9x2l3mxrdufkh4pg53wecv6kn09u0suk2lys

Roger Song business mainstream:perspective

11/17/2025

npub1vap2usg…grwc3n

JUST THE TONIC: THIS MEDICAL STOCK, A MUTUAL FUND DARLING, TESTS ENTRY AMID 58% RUN

https://www.investors.com/wp-content/uploads/2025/07/Stock-Money-pointGlasses-shut.jpg

✍️ Kiniksa Pharmaceuticals International (KNSA) is experiencing a powerful run, with institutional investors loading up on the stock, driven by its flagship drug Arcalyst and expected rebound to profitability.

-- #WilliamJ.O'Neil #RogerSong #GeoffMeacham #MichaelLarkin #Bermuda #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqc0nka9ca87yztkw7z2z8p9c2ng7w5xc6f303lvthhj396ezt7lqqg5cjea

William J. O'Neil Roger Song Geoff Meacham Michael Larkin Bermuda health mainstream:perspective

8/1/2025

npub1n5e52z2…j27swa

FDA’S TOP VACCINE OFFICIAL LEAVES POST AFTER LESS THAN FOUR MONTHS

https://i.guim.co.uk/img/media/be7750f0b599996aa2bf6d4a7688b18d98929079/465_0_4652_3725/master/4652.jpg?width=140&quality=85&auto=format&fit=max&s=dce915b4d60bb06ffeb2c6bd61f50880

✍️ Vinay Prasad, the top vaccine official at the US FDA, has left the agency less than four months after being appointed, citing a desire to spend more time with his family.

-- #VinayPrasad #KostasBilouris #RogerSong #UnitedStates #California #Washington #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzp8fng5y4axrdakd0wfxjd2x9hms9p07kzhpjl308dxq6pzw8yqywqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq98hv9eu4jzke3y9snxq5z7uxlupq4keflc7ypvsnchxsna7q6cfq7hclsu

Vinay Prasad Kostas Bilouris Roger Song United States California Washington health liberal:perspective

7/30/2025

npub1vap2usg…grwc3n

JEFFERIES PREDICTS UP TO ~1000% SURGE FOR THESE 2 ‘STRONG BUY’ STOCKS

https://media.zenfs.com/en/tipranks_452/fb203f95ffee9f374f54e6aa062b8ef8

✍️ The article discusses the potential impact of a second Trump administration on the biotech sector, with Jefferies analysts predicting a growth-friendly environment and identifying two small biotech stocks with strong upside.

-- #DeshPeramunetilleke #MauryRaycroft #RogerSong #health

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqx65jkkx0e47xtdke9tvyqyaqg74436faw28rw764l64pm602wcwqwcn280

Desh Peramunetilleke Maury Raycroft Roger Song health mainstream:perspective

12/8/2024